These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 9828216
61. Enzyme-linked immunosorbent assay for serum procollagen type III peptide in rats with hepatic fibrosis. Cho JJ, Lee YS. J Vet Med Sci; 1998 Nov; 60(11):1213-20. PubMed ID: 9853302 [Abstract] [Full Text] [Related]
62. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. Sugihara A, Tsujimura T, Fujita Y, Nakata Y, Terada N. J Hepatol; 1999 May; 30(5):859-67. PubMed ID: 10365813 [Abstract] [Full Text] [Related]
63. [Effect of emodin on development of hepatic fibrosis in rats]. Zhan Y, Li D, Wei H. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr; 20(4):276-8. PubMed ID: 11789266 [Abstract] [Full Text] [Related]
64. Antifibrotic effects of the methanol extract of Polygonum aviculare in fibrotic rats induced by bile duct ligation and scission. Nan JX, Park EJ, Kim HJ, Ko G, Sohn DH. Biol Pharm Bull; 2000 Feb; 23(2):240-3. PubMed ID: 10706393 [Abstract] [Full Text] [Related]
65. Haemodynamic effects of 8-day octreotide and prazosin administration in portal hypertensive rats. Lin HC, Wu HL, Huang YT, Hou MC, Lee SD, Hong CY. Eur J Clin Invest; 1998 Aug; 28(8):622-8. PubMed ID: 9767356 [Abstract] [Full Text] [Related]
67. Effects of long-term propranolol and octreotide on postprandial hemodynamics in cirrhosis: a randomized, controlled trial. Vorobioff JD, Gamen M, Kravetz D, Picabea E, Villavicencio R, Bordato J, Ruf A, Bessone F, Romero G, Palazzi J, Nicora A, Passamonti M, Tanno H. Gastroenterology; 2002 Apr; 122(4):916-22. PubMed ID: 11910343 [Abstract] [Full Text] [Related]
68. Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis. Vollmar B, Wolf B, Siegmund S, Katsen AD, Menger MD. Am J Pathol; 1997 Jul; 151(1):169-75. PubMed ID: 9212743 [Abstract] [Full Text] [Related]
69. A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats. Muguerza B, Lecároz C, Picardi A, Castilla-Cortázar I, Quiroga J, Cemborain A, Prieto J, Santidrián S. Rev Esp Fisiol; 1996 Jun; 52(2):113-9. PubMed ID: 8870109 [Abstract] [Full Text] [Related]
70. Alterations in liver blood flow and reticuloendothelial function in progressive cirrhosis in the rat. Goeting NL, Fleming JS, Gallagher P, Walmsely BH, Karran SJ. J Nucl Med; 1986 Nov; 27(11):1751-4. PubMed ID: 3772508 [Abstract] [Full Text] [Related]
71. Hemodynamic studies of cirrhosis in the dog. Kreuzer W, Schueller EF, Schenk WG. Surg Gynecol Obstet; 1972 Jul; 135(1):89-93. PubMed ID: 5032635 [No Abstract] [Full Text] [Related]
72. Arterialisation of the portal vein as a model for the induction of hepatic fibrosis: description of microsurgical models in the rat. Müller V, Brummer D, Erhardt W, Henke J, Kissler H, Bauer M, Amann K, Ott R, Hohenberger W. Transpl Int; 2005 May; 17(12):822-33. PubMed ID: 15827755 [Abstract] [Full Text] [Related]
73. Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis. Klein S, Herath CB, Schierwagen R, Grace J, Haltenhof T, Uschner FE, Strassburg CP, Sauerbruch T, Walther T, Angus PW, Trebicka J. PLoS One; 2015 May; 10(9):e0138732. PubMed ID: 26406236 [Abstract] [Full Text] [Related]
74. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ. Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330 [Abstract] [Full Text] [Related]
75. Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression. Guo SB, Li Q, Duan ZJ, Wang QM, Zhou Q, Sun XY. Mol Med Rep; 2015 Jan; 11(1):83-90. PubMed ID: 25338529 [Abstract] [Full Text] [Related]
76. High, but not low, dietary retinoids aggravate manifestation of rat liver fibrosis. Vollmar B, Heckmann C, Richter S, Menger MD. J Gastroenterol Hepatol; 2002 Jul; 17(7):791-9. PubMed ID: 12121510 [Abstract] [Full Text] [Related]
77. [Effects of octreotide (somatostatin analog SMS 201-995) on superior mesenteric artery blood flow in swine. An experimental study using Doppler color ultrasonography]. Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Miccini M. G Chir; 1999 Jul; 20(1-2):9-13. PubMed ID: 10097449 [Abstract] [Full Text] [Related]
78. Somatostatin analogue (SMS 201-995) but not somatostatin reduces indocyanine green clearance in the portal hypertensive rat. Kimchi N, Krepel Z, Ronen E, Bar-Meir E, Bruck R, Bar-Meir S. Isr J Med Sci; 1993 Jan; 29(1):37-9. PubMed ID: 8095929 [No Abstract] [Full Text] [Related]
79. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Ruwart MJ, Wilkinson KF, Rush BD, Vidmar TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D, Hahn EG. Hepatology; 1989 Nov; 10(5):801-6. PubMed ID: 2807158 [Abstract] [Full Text] [Related]
80. [Sclerotic changes in the liver in experimental cholestasis and their reversibility following restoration of bile outflow]. Zufarov KA, Sadriddinov AF. Biull Eksp Biol Med; 1986 Jul; 102(7):105-8. PubMed ID: 3730576 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]